Cognitive Functions in Adults With Sickle Cell Disease and Cognitive Complaints: Neuropsychological Assessment and Links to Demographic, Clinical, Biological, Neuroradiological Outcomes and Validation of a Cognitive Assessment Tool.

About the study

Sickle cell disease (SCD) is an inherited blood disorder. Symptoms include acute and chronic complications. Due to progress in SCD care, patients with SCD are living longer than before and we focus more attention in chronic complications.

Children with SCD experience worse cognitive functions than healthy children, and fewer is known about cognitive functions in adults. Studies suggest lower cognitive performance in SCD, mostly in executive functions and processing speed, but the biological and anatomical substrates of cognitive decline are not yet well established in SCD. Often times, cognitive impairments and cerebral disorders are not diagnosed and treated in adults with SCD.

The main objective of this study is to propose a deep neuropsychological assessment in adults with SCD and cognitive complaints and to highlight links between cognitive functions and clinical, biological and neuroradiological markers. The hypothesis of this study is that cognitive functions are associated with severity of the SCD, with bood abnormalities, with MRI markers and Transcranial Doppler (TCD) markers of cerebrovascular disease. The secondary objective of this study is to validate a brief cognitive assessment tool (BEARNI tool) in adults with SCD.

This study is an observational cross-sectional study that will enroll adults with SCD and cognitive complaint.

Study point of contact

Romain FORT, MD, PhD
04 72 11 91 85
04 72 43 21 27


1 France site


> 18 Years

Study type






participation requirements

Age ≥ 18 years old
Sickle cell anemia (homozygous SS or heterozygous SC, Sβ0, S/C, Sβ+)
In steady state (without vaso-occlusive crisis or acute chest syndrome at the time of measurements)
Presence of spontaneous cognitive complaint or requested by the physician.
Good command of the French language (native language or not)
No objection to participate in the study
Affiliated patient or beneficiary of social security scheme

participation restrictions

Patient not compliant in the management of his disease
Patient participating in another interventional research protocol that may interfere with this protocol (according to investigator’s judgment)
Language barrier
Pregnancy or breast feeding
MRI contraindication
Patient under guardianship , curatorship or justice
Inability to express non-opposition


  • Bron, France, Hôpital Edouard Herriot, 69437 [Recruiting]
Last updated 2022-03-23